AI system can equal or surpass ophthalmologists in diagnosis, treatment of glaucoma and retina disorders
Can't see this email? View it online
   
  Ophthalmology / Optometry  
  The latest ophthalmology / optometry news from News Medical  
 Gut bacteria may be responsible for sight loss in certain inherited eye diseasesGut bacteria may be responsible for sight loss in certain inherited eye diseases
 
Sight loss in certain inherited eye diseases may be caused by gut bacteria, and is potentially treatable by antimicrobials, finds a new study in mice co-led by a UCL and Moorfields researcher.
 
 
 AI system can equal or surpass ophthalmologists in diagnosis, treatment of glaucoma and retina disordersAI system can equal or surpass ophthalmologists in diagnosis, treatment of glaucoma and retina disorders
 
A large language model (LLM) artificial intelligence (AI) system can match, or in some cases outperform, human ophthalmologists in the diagnosis and treatment of patients with glaucoma and retina disease, according to research from New York Eye and Ear Infirmary of Mount Sinai (NYEE).
 
   Genetic risk tool could aid early diagnosis and treatment of multiple sclerosis patientsGenetic risk tool could aid early diagnosis and treatment of multiple sclerosis patients
 
Young people could be spared from going blind by a new genetic risk tool that could also help diagnose multiple sclerosis (MS) earlier, to start effective treatments.
 
   Exonate first-in-class eye drop Phase Ib/IIa trial data demonstrate safety and biological activity in treatment of diabetic retinopathy and diabetic macular oedemaExonate first-in-class eye drop Phase Ib/IIa trial data demonstrate safety and biological activity in treatment of diabetic retinopathy and diabetic macular oedema
 
EXN407 is the first topical SRPK1 inhibitor to demonstrate both safety and signals of biological response as monotherapy for these indications.
 
 Researchers develop new tool to rapidly and inexpensively diagnose sarcoidosis
 
Researchers develop new tool to rapidly and inexpensively diagnose sarcoidosisA research project supported by the National Institutes of Health has developed a tool to rapidly and inexpensively diagnose sarcoidosis, a chronic inflammatory disease marked by the growth of tiny lumps called granulomas in the lungs and other organs in the body.
 
 
 Researchers take important step toward genetic therapy for hereditary conditions
 
Researchers take important step toward genetic therapy for hereditary conditionsResearchers who work with tiny drug carriers known as lipid nanoparticles have developed a new type of material capable of reaching the lungs and the eyes, an important step toward genetic therapy for hereditary conditions like cystic fibrosis and inherited vision loss.